Literature DB >> 6386459

Changing fecal Escherichia coli flora during travel.

F Orskov, R B Sack, I Orskov, J L Froelich.   

Abstract

The Escherichia coli flora of 23 Peace-Corps volunteers were monitored during the first six weeks of their stay in Morocco. Fifteen (65%) had a total of 21 diarrheal episodes, six of which were associated with enterotoxigenic Escherichia coli. Bioserotypes O25:K7:H42, O128:H-, O169:H- and O20H- were found. These or other characteristically enterotoxigenic Escherichia coli bioserotypes were not found in asymptomatic persons, except in one case. In general, the Escherichia coli flora not only changed after the volunteers arrived in Morocco but continued to change during the six weeks of investigation.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6386459     DOI: 10.1007/bf01977478

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  10 in total

1.  Further observations on the persistence of individual strains of Escherichia coli in the intestinal tract of man.

Authors:  H J SEARS; I BROWNLEE
Journal:  J Bacteriol       Date:  1952-01       Impact factor: 3.490

2.  Persistence of individual strains of Escherichia coli in the intestinal tract of man.

Authors:  H J SEARS; I BROWNLEE; J K UCHIYAMA
Journal:  J Bacteriol       Date:  1950-02       Impact factor: 3.490

3.  Prophylactic doxycycline for travelers' diarrhea: results of a prospective double-blind study of Peace Corps volunteers in Morocco.

Authors:  R B Sack; J L Froehlich; A W Zulich; D S Hidi; A Z Kapikian; F Orskov; I Orskov; H B Greenberg
Journal:  Gastroenterology       Date:  1979-06       Impact factor: 22.682

4.  Fate of ingested Escherichia coli in normal persons.

Authors:  E M Cooke; I G Hettiaratchy; A C Buck
Journal:  J Med Microbiol       Date:  1972-08       Impact factor: 2.472

5.  [Stability of coli flora of the healthy human. 1. The occurrence of permanent and changing types].

Authors:  B Wiedemann; H Knothe
Journal:  Arch Hyg Bakteriol       Date:  1969-08

6.  Use of antisera for identification of enterotoxigenic Escherichia coli.

Authors:  M H Merson; B Rowe; R E Black; I Huq; R J Gross; A Eusof
Journal:  Lancet       Date:  1980-08-02       Impact factor: 79.321

7.  Test for enterotoxigenic Escherichia coli using Y-1 adrenal cells in miniculture.

Authors:  D A Sack; R B Sack
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

8.  Escherichia coli serotypes in the faeces of healthy adults over a period of several months.

Authors:  R A Shooter; K A Bettleheim; S M Lennox-King; S O'Farrell
Journal:  J Hyg (Lond)       Date:  1977-02

9.  Test for Escherichia coli enterotoxin using infant mice: application in a study of diarrhea in children in Honolulu.

Authors:  A G Dean; Y C Ching; R G Williams; L B Harden
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

10.  Changes in serotype and resistance pattern of the intestinal Escherichia coli flora during travel. Results from a trial of mecillinam as a prophylactic against travellers' diarrhoea.

Authors:  J Stenderup; I Orskov; F Orskov
Journal:  Scand J Infect Dis       Date:  1983
  10 in total
  3 in total

1.  Analysis of Escherichia coli isolates from subjects with travellers' diarrhoea using DNA probes and serotyping.

Authors:  C M Rademaker; M R Krul; W H Jansen; N M Vos; I M Hoepelman; M Rozenberg-Arska; J Verhoef
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-08       Impact factor: 3.267

2.  Emergence of resistant fecal Escherichia coli in travelers not taking prophylactic antimicrobial agents.

Authors:  B E Murray; J J Mathewson; H L DuPont; C D Ericsson; R R Reves
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

3.  Effect of iron on serotypes and haemagglutination patterns of Escherichia coli in bottle-fed infants.

Authors:  E A Mevissen-Verhage; J H Marcelis; P A Guinée; J Verhoef
Journal:  Eur J Clin Microbiol       Date:  1985-12       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.